Russo Rene (CIK 1722066) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-05). Recent activity: Buy XLO (44,250 shares), Buy XLO (36,289 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-05 | Xilio Therapeutics, Inc. (XLO) | PRESIDENT AND CEO | Buy | 44,250 | $0 |
| 2025-06-18 | Xilio Therapeutics, Inc. (XLO) | PRESIDENT AND CEO | Buy | 36,289 | $0 |
Source: SEC Form 4 filings · as of 2026-01-05